axhidrox 2,2 mg/hub creme
dr. august wolff gmbh & co. kg arzneimittel (3092095) - glycopyrroniumbromid (ph.eur.) - creme - 2,2 mg/hub - teil 1 - creme; glycopyrroniumbromid (ph.eur.) (09529) 2,75 milligramm
rybrila 160 mikrogramm/ml lösung zum einnehmen
clinigen healthcare b.v. - glycopyrroniumbromid -
robinul 0,2 mg - ampullen
esteve pharmaceuticals gmbh - glycopyrroniumbromid - glycopyrronium
axhidrox 2,2 mg/pumpenhub creme
dr. august wolff gmbh & co. kg - arzneimittel - glycopyrroniumbromid -
glycopyrronium curamed
curamed pharma gmbh - glycopyrroniumbromid (ph.eur.) - injektionslösung - glycopyrroniumbromid (ph.eur.) 0.2mg
ultibro breezhaler 110/50 hartkapseln mit pulver zur inhalation
novartis pharma schweiz ag - indacaterolum, glycopyrronium - hartkapseln mit pulver zur inhalation - indacaterolum 110 µg ut indacateroli maleas, glycopyrronium 50 µg ut glycopyrronii bromidum, lactosum monohydricum, magnesii stearas, pro capsula. - chronisch obstruktive lungenkrankheit (copd) - synthetika
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asthma - medikamente für obstruktive atemwegserkrankungen, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - asthma - medikamente für obstruktive atemwegserkrankungen, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
enurev breezhaler
novartis europharm ltd - glycopyrronium bromide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - enurev breezhaler wird als bronchodilatator erhaltungstherapie zur linderung der symptome bei erwachsenen patienten mit chronisch obstruktiver lungenerkrankung (copd) angegeben..